1978
DOI: 10.1016/s0022-3476(78)80315-1
|View full text |Cite
|
Sign up to set email alerts
|

Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
26
0
2

Year Published

1979
1979
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 61 publications
(29 citation statements)
references
References 10 publications
1
26
0
2
Order By: Relevance
“…As a result, we are intensifying our chelation efforts in patients with abnormal methoxamine challenge tests in an attempt to improve their clinical well-being. [35][36][37] We hope that the PES-DEs relation determined serially in patients with thalassemia major will prove predictive, and thus aid in the development of improved therapeutic alternatives for this disease, chronic LV volume overload from valvular regurgitation, and others in which progressive cardiomyopathy is a hallmark. Our preliminary results in patients receiving adriamycin indicate that this might be the case.38 39 …”
Section: End-systolic Pressure-dimension Relationmentioning
confidence: 99%
“…As a result, we are intensifying our chelation efforts in patients with abnormal methoxamine challenge tests in an attempt to improve their clinical well-being. [35][36][37] We hope that the PES-DEs relation determined serially in patients with thalassemia major will prove predictive, and thus aid in the development of improved therapeutic alternatives for this disease, chronic LV volume overload from valvular regurgitation, and others in which progressive cardiomyopathy is a hallmark. Our preliminary results in patients receiving adriamycin indicate that this might be the case.38 39 …”
Section: End-systolic Pressure-dimension Relationmentioning
confidence: 99%
“…Traditional therapy for this complication is iron chelating-agents that enhance the urinary excretion of irons. [14,15] Later these irons may be deposited in different tissues/organs of the patients getting red blood cells transfusions, usually more than 100 units of conventional packed red blood cells transfusions and produce siderosis and its sequel: growth failure, hypogonadism, diabetes mellitus, hepatic disease, cardiac failure and death.…”
Section: Introductionmentioning
confidence: 99%
“…β-thalassemia major is an autosomal recessive genetic disorder, which is clinically; the most severe form and the affected child is dependent on regular blood transfusion for survival [2]. The current management of β-thalassemia major patient is based on regular transfusion of packed red cells and effective chelating therapy [3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%